1-2 of 2
Peter Dreger, Prof. Dr. med.
Close
Sort by
Journal Articles

High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation (ASCT) Has a Significant but Transient Impact on Quality of Life: Lessons From the Chronic Lymphocytic Leukemia (CLL) ASCT Study by the CLL Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Liesbeth C. de Wreede, PhD, Maggie Watson, Donald Milligan, MD, MBChB, Mauricette Michallet, Peter Dreger, Prof. Dr. med., Marleen van Os, Claire E. Dearden, Catherine Cordonnier, Michel Leporrier, MD, Vladimir Koza, MD, Janis Homewood, Bernadette Corront, MD, Gabriela M. Baerlocher, MD, Wolfgang Herr, Dietger Niederwieser, MD, Laurent Sutton, Theo M. de Witte, MD, Johannes Schetelig, MD
Journal: Blood
Blood (2011) 118 (21): 1989.
https://doi.org/10.1182/blood.V118.21.1989.1989
Published: 2011
Journal Articles

Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Interim Analysis of a Phase II Study of the GCLLSG and fcgcll/MW

Stephan Stilgenbauer, Prof. Dr. med, Florence Cymbalista, Pr, Véronique Leblond, Pr, Alain Delmer, MD, Dirk Winkler, MD, Andreas Bühler, Dr. med., Thorsten Zenz, Prof. Dr. med., Silja Mack, Raymonde Busch, Dipl.-Math., Axel Hinke, Dr., Sylvain Choquet, MD, Caroline Dartigeas, Dr., Bruno Cazin, Dr., Olivier Tournilhac, MD, PhD, Michael Rieger, MD, Jürgen Alt, Dr. med, Martin Sökler, Dr. med, Johannes Schetelig, MD, Peter Dreger, Prof. Dr. med., Michael Hallek, MD, Hartmut Döhner, Prof. Dr. med.
Journal: Blood
Blood (2011) 118 (21): 2854.
https://doi.org/10.1182/blood.V118.21.2854.2854
Published: 2011